{"id":"https://openalex.org/W2321142363","doi":"https://doi.org/10.1038/mt.2015.43","title":"Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma","display_name":"Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma","alternate_titles":[],"publication_year":2015,"publication_date":"2015-04-28","ids":{"openalex":"https://openalex.org/W2321142363","doi":"https://doi.org/10.1038/mt.2015.43","mag":"2321142363","pmid":"https://pubmed.ncbi.nlm.nih.gov/25917459","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4817748"},"language":"en","primary_location":{"id":"doi:10.1038/mt.2015.43","doi":"https://doi.org/10.1038/mt.2015.43","is_oa":true,"landing_page_url":"https://doi.org/10.1038/mt.2015.43","pdf_url":null,"source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2321142363"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1038/mt.2015.43","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065653743","display_name":"Maurizio L. Ghisoli","orcid":"https://orcid.org/0000-0001-7055-2618","observed_orcids":["https://orcid.org/0000-0001-7055-2618"]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]},{"id":"https://openalex.org/I2800474951","display_name":"Medical City Dallas Hospital","ror":"https://ror.org/059rc1n32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800474951"]},{"id":"https://openalex.org/I4210087725","display_name":"Mary Crowley Cancer Research Center","ror":"https://ror.org/002ksg449","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210087725"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maurizio Ghisoli","raw_affiliation_strings":["Mary Crowley Cancer Research Centers, Dallas, Texas, USA; Texas Oncology, P.A., Dallas, Texas, USA; Medical City Dallas Hospital, Dallas, Texas, USA","Mary Crowley Cancer Research Centers, Dallas, Texas, USA","Medical City Dallas Hospital, Dallas, Texas, USA","Texas Oncology, P.A., Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mary Crowley Cancer Research Centers, Dallas, Texas, USA; Texas Oncology, P.A., Dallas, Texas, USA; Medical City Dallas Hospital, Dallas, Texas, USA","institution_ids":["https://openalex.org/I2800474951","https://openalex.org/I4210087725"]},{"raw_affiliation_string":"Mary Crowley Cancer Research Centers, Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210087725"]},{"raw_affiliation_string":"Medical City Dallas Hospital, Dallas, Texas, USA","institution_ids":["https://openalex.org/I2800474951"]},{"raw_affiliation_string":"Texas Oncology, P.A., Dallas, Texas, USA","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015591858","display_name":"Minal A. Barve","orcid":"https://orcid.org/0009-0007-4259-7457","observed_orcids":["https://orcid.org/0009-0007-4259-7457"]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]},{"id":"https://openalex.org/I4210087725","display_name":"Mary Crowley Cancer Research Center","ror":"https://ror.org/002ksg449","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210087725"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Minal Barve","raw_affiliation_strings":["Mary Crowley Cancer Research Centers, Dallas, Texas, USA; Texas Oncology, P.A., Dallas, Texas, USA","Mary Crowley Cancer Research Centers, Dallas, Texas, USA","Texas Oncology, P.A., Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mary Crowley Cancer Research Centers, Dallas, Texas, USA; Texas Oncology, P.A., Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210087725"]},{"raw_affiliation_string":"Mary Crowley Cancer Research Centers, Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210087725"]},{"raw_affiliation_string":"Texas Oncology, P.A., Dallas, Texas, USA","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053736790","display_name":"Reva Schneider","orcid":"https://orcid.org/0009-0003-5570-7601","observed_orcids":["https://orcid.org/0009-0003-5570-7601"]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]},{"id":"https://openalex.org/I4210087725","display_name":"Mary Crowley Cancer Research Center","ror":"https://ror.org/002ksg449","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210087725"]},{"id":"https://openalex.org/I4210094538","display_name":"Gradalis (United States)","ror":"https://ror.org/00jv1ms45","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094538"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Reva Schneider","raw_affiliation_strings":["Mary Crowley Cancer Research Centers, Dallas, Texas, USA; Texas Oncology, P.A., Dallas, Texas, USA; Gradalis, Inc., Dallas, Texas, USA","Gradalis, Inc., Dallas, Texas, USA","Mary Crowley Cancer Research Centers, Dallas, Texas, USA","Texas Oncology, P.A., Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mary Crowley Cancer Research Centers, Dallas, Texas, USA; Texas Oncology, P.A., Dallas, Texas, USA; Gradalis, Inc., Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210087725","https://openalex.org/I4210094538"]},{"raw_affiliation_string":"Gradalis, Inc., Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210094538"]},{"raw_affiliation_string":"Mary Crowley Cancer Research Centers, Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210087725"]},{"raw_affiliation_string":"Texas Oncology, P.A., Dallas, Texas, USA","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002951950","display_name":"Robert Gary Mennel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]},{"id":"https://openalex.org/I2802366037","display_name":"Baylor University Medical Center","ror":"https://ror.org/03nxfhe13","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802366037","https://openalex.org/I4210160418"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert Mennel","raw_affiliation_strings":["Texas Oncology, P.A., Dallas, Texas, USA; Baylor University Medical Center, Dallas, Texas, USA","Baylor University Medical Center, Dallas, Texas, USA","Texas Oncology, P.A., Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Oncology, P.A., Dallas, Texas, USA; Baylor University Medical Center, Dallas, Texas, USA","institution_ids":["https://openalex.org/I2802366037"]},{"raw_affiliation_string":"Baylor University Medical Center, Dallas, Texas, USA","institution_ids":["https://openalex.org/I2802366037"]},{"raw_affiliation_string":"Texas Oncology, P.A., Dallas, Texas, USA","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039098373","display_name":"Carl Lenarsky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]},{"id":"https://openalex.org/I2800474951","display_name":"Medical City Dallas Hospital","ror":"https://ror.org/059rc1n32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800474951"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carl Lenarsky","raw_affiliation_strings":["Texas Oncology, P.A., Dallas, Texas, USA; Medical City Dallas Hospital, Dallas, Texas, USA","Medical City Dallas Hospital, Dallas, Texas, USA","Texas Oncology, P.A., Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Oncology, P.A., Dallas, Texas, USA; Medical City Dallas Hospital, Dallas, Texas, USA","institution_ids":["https://openalex.org/I2800474951"]},{"raw_affiliation_string":"Medical City Dallas Hospital, Dallas, Texas, USA","institution_ids":["https://openalex.org/I2800474951"]},{"raw_affiliation_string":"Texas Oncology, P.A., Dallas, Texas, USA","institution_ids":["https://openalex.org/I2800124591"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052040011","display_name":"Gladice Wallraven","orcid":"https://orcid.org/0000-0002-2145-3565","observed_orcids":["https://orcid.org/0000-0002-2145-3565"]},"institutions":[{"id":"https://openalex.org/I4210094538","display_name":"Gradalis (United States)","ror":"https://ror.org/00jv1ms45","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094538"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gladice Wallraven","raw_affiliation_strings":["Gradalis, Inc., Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gradalis, Inc., Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210094538"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088629605","display_name":"Beena O. Pappen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094538","display_name":"Gradalis (United States)","ror":"https://ror.org/00jv1ms45","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094538"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Beena O Pappen","raw_affiliation_strings":["Gradalis, Inc., Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gradalis, Inc., Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210094538"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028401694","display_name":"John LaNoue","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142711","display_name":"Medical City Children's Hospital","ror":"https://ror.org/04253q669","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210142711"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John LaNoue","raw_affiliation_strings":["Medical City Children's Hospital, Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical City Children's Hospital, Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210142711"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111493282","display_name":"Padmasini Kumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094538","display_name":"Gradalis (United States)","ror":"https://ror.org/00jv1ms45","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094538"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Padmasini Kumar","raw_affiliation_strings":["Gradalis, Inc., Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gradalis, Inc., Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210094538"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010410321","display_name":"Derek Nemunaitis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087725","display_name":"Mary Crowley Cancer Research Center","ror":"https://ror.org/002ksg449","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210087725"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Derek Nemunaitis","raw_affiliation_strings":["Mary Crowley Cancer Research Centers, Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mary Crowley Cancer Research Centers, Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210087725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017349687","display_name":"Alyssa Roth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087725","display_name":"Mary Crowley Cancer Research Center","ror":"https://ror.org/002ksg449","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210087725"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alyssa Roth","raw_affiliation_strings":["Mary Crowley Cancer Research Centers, Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mary Crowley Cancer Research Centers, Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210087725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104321263","display_name":"James Nemunaitis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087725","display_name":"Mary Crowley Cancer Research Center","ror":"https://ror.org/002ksg449","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210087725"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James Nemunaitis","raw_affiliation_strings":["Mary Crowley Cancer Research Centers, Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mary Crowley Cancer Research Centers, Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210087725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5143820676","display_name":"Sam Whiting","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094538","display_name":"Gradalis (United States)","ror":"https://ror.org/00jv1ms45","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094538"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sam Whiting","raw_affiliation_strings":["Gradalis, Inc., Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gradalis, Inc., Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210094538"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111839131","display_name":"Neil N. Senzer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087725","display_name":"Mary Crowley Cancer Research Center","ror":"https://ror.org/002ksg449","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210087725"]},{"id":"https://openalex.org/I4210094538","display_name":"Gradalis (United States)","ror":"https://ror.org/00jv1ms45","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094538"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Neil Senzer","raw_affiliation_strings":["Mary Crowley Cancer Research Centers, Dallas, Texas, USA; Gradalis, Inc., Dallas, Texas, USA","Gradalis, Inc., Dallas, Texas, USA","Mary Crowley Cancer Research Centers, Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mary Crowley Cancer Research Centers, Dallas, Texas, USA; Gradalis, Inc., Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210087725","https://openalex.org/I4210094538"]},{"raw_affiliation_string":"Gradalis, Inc., Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210094538"]},{"raw_affiliation_string":"Mary Crowley Cancer Research Centers, Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210087725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113517204","display_name":"Frederick A. Fletcher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094538","display_name":"Gradalis (United States)","ror":"https://ror.org/00jv1ms45","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094538"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Frederick A Fletcher","raw_affiliation_strings":["Gradalis, Inc., Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gradalis, Inc., Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210094538"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055054082","display_name":"John J. Nemunaitis","orcid":"https://orcid.org/0000-0002-2234-2381","observed_orcids":["https://orcid.org/0000-0002-2234-2381"]},"institutions":[{"id":"https://openalex.org/I2800124591","display_name":"Texas Oncology","ror":"https://ror.org/02ketev28","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800124591"]},{"id":"https://openalex.org/I2800474951","display_name":"Medical City Dallas Hospital","ror":"https://ror.org/059rc1n32","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800474951"]},{"id":"https://openalex.org/I4210087725","display_name":"Mary Crowley Cancer Research Center","ror":"https://ror.org/002ksg449","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210087725"]},{"id":"https://openalex.org/I4210094538","display_name":"Gradalis (United States)","ror":"https://ror.org/00jv1ms45","country_code":"US","type":"company","lineage":["https://openalex.org/I4210094538"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"John Nemunaitis","raw_affiliation_strings":["Mary Crowley Cancer Research Centers, Dallas, Texas, USA; Texas Oncology, P.A., Dallas, Texas, USA; Gradalis, Inc., Dallas, Texas, USA; Medical City Dallas Hospital, Dallas, Texas, USA. Electronic address: jnemunaitis@marycrowley.org","Gradalis, Inc., Dallas, Texas, USA","Mary Crowley Cancer Research Centers, Dallas, Texas, USA","Medical City Dallas Hospital, Dallas, Texas, USA","Texas Oncology, P.A., Dallas, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mary Crowley Cancer Research Centers, Dallas, Texas, USA; Texas Oncology, P.A., Dallas, Texas, USA; Gradalis, Inc., Dallas, Texas, USA; Medical City Dallas Hospital, Dallas, Texas, USA. Electronic address: jnemunaitis@marycrowley.org","institution_ids":["https://openalex.org/I2800474951","https://openalex.org/I4210087725","https://openalex.org/I4210094538"]},{"raw_affiliation_string":"Gradalis, Inc., Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210094538"]},{"raw_affiliation_string":"Mary Crowley Cancer Research Centers, Dallas, Texas, USA","institution_ids":["https://openalex.org/I4210087725"]},{"raw_affiliation_string":"Medical City Dallas Hospital, Dallas, Texas, USA","institution_ids":["https://openalex.org/I2800474951"]},{"raw_affiliation_string":"Texas Oncology, P.A., Dallas, Texas, USA","institution_ids":["https://openalex.org/I2800124591"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5055054082"],"corresponding_institution_ids":["https://openalex.org/I2800124591","https://openalex.org/I2800474951","https://openalex.org/I4210087725","https://openalex.org/I4210094538"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":2.4438,"has_fulltext":true,"cited_by_count":56,"citation_normalized_percentile":{"value":0.89082936,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"23","issue":"6","first_page":"1103","last_page":"1109"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7235999703407288,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.7235999703407288,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.23010000586509705,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.00930000003427267,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ewing-sarcoma","display_name":"Ewing sarcoma","score":0.9049999713897705},{"id":"https://openalex.org/keywords/autologous-tumor-cell-vaccine","display_name":"autologous tumor cell vaccine","score":0.8619999885559082},{"id":"https://openalex.org/keywords/intradermal-vaccination","display_name":"intradermal vaccination","score":0.8119999766349792},{"id":"https://openalex.org/keywords/tumor-specific-immunity","display_name":"tumor-specific immunity","score":0.8859999775886536},{"id":"https://openalex.org/keywords/gm-csf","display_name":"GM-CSF","score":0.9229999780654907},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4309999942779541},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.6060000061988831},{"id":"https://openalex.org/keywords/metastatic-sarcoma","display_name":"metastatic sarcoma","score":0.7749999761581421}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6081503033638},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.6040668487548828},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5276690125465393},{"id":"https://openalex.org/C2777586341","wikidata":"https://www.wikidata.org/wiki/Q1138580","display_name":"Ewing's sarcoma","level":3,"score":0.4941118061542511},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46527478098869324},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4642195701599121},{"id":"https://openalex.org/C2778774319","wikidata":"https://www.wikidata.org/wiki/Q1940269","display_name":"Fang","level":2,"score":0.4348510205745697},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37057989835739136},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3656172752380371},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27522575855255127},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.14363276958465576},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.14028838276863098},{"id":"https://openalex.org/C90856448","wikidata":"https://www.wikidata.org/wiki/Q431","display_name":"Zoology","level":1,"score":0.07261568307876587}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005786","descriptor_name":"Gene Expression Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012512","descriptor_name":"Sarcoma, Ewing","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D016178","descriptor_name":"Granulocyte-Macrophage Colony-Stimulating Factor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016178","descriptor_name":"Granulocyte-Macrophage Colony-Stimulating Factor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053773","descriptor_name":"Transforming Growth Factor beta1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D053773","descriptor_name":"Transforming Growth Factor beta1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053781","descriptor_name":"Transforming Growth Factor beta2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D053781","descriptor_name":"Transforming Growth Factor beta2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/mt.2015.43","doi":"https://doi.org/10.1038/mt.2015.43","is_oa":true,"landing_page_url":"https://doi.org/10.1038/mt.2015.43","pdf_url":null,"source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4817748","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4817748/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4817748/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Ther","raw_type":"Text"},{"id":"pmid:25917459","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25917459","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular therapy : the journal of the American Society of Gene Therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1038/mt.2015.43","doi":"https://doi.org/10.1038/mt.2015.43","is_oa":true,"landing_page_url":"https://doi.org/10.1038/mt.2015.43","pdf_url":null,"source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306085","display_name":"U.S. Department of Health and Human Services","ror":"https://ror.org/033jnv181"},{"id":"https://openalex.org/F4320307490","display_name":"Wilson Foundation","ror":"https://ror.org/03py6vn41"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2321142363.pdf","grobid_xml":"https://content.openalex.org/works/W2321142363.grobid-xml"},"referenced_works_count":64,"referenced_works":["https://openalex.org/W1528827595","https://openalex.org/W1533392829","https://openalex.org/W1539607590","https://openalex.org/W1557164803","https://openalex.org/W1562422876","https://openalex.org/W1592041923","https://openalex.org/W1896775015","https://openalex.org/W1973591487","https://openalex.org/W1973805241","https://openalex.org/W1984162437","https://openalex.org/W1987657194","https://openalex.org/W1989583074","https://openalex.org/W1990390825","https://openalex.org/W1991937882","https://openalex.org/W2006492631","https://openalex.org/W2007768242","https://openalex.org/W2008324714","https://openalex.org/W2014071641","https://openalex.org/W2014605710","https://openalex.org/W2018972324","https://openalex.org/W2027392829","https://openalex.org/W2034269086","https://openalex.org/W2038481383","https://openalex.org/W2038774702","https://openalex.org/W2046131550","https://openalex.org/W2049762189","https://openalex.org/W2050470657","https://openalex.org/W2056095697","https://openalex.org/W2058006748","https://openalex.org/W2067431214","https://openalex.org/W2068868975","https://openalex.org/W2071919091","https://openalex.org/W2072315137","https://openalex.org/W2072909107","https://openalex.org/W2073272563","https://openalex.org/W2074604431","https://openalex.org/W2075704804","https://openalex.org/W2087863947","https://openalex.org/W2089001167","https://openalex.org/W2096882042","https://openalex.org/W2103460784","https://openalex.org/W2104557203","https://openalex.org/W2107433579","https://openalex.org/W2113313714","https://openalex.org/W2118541332","https://openalex.org/W2122081319","https://openalex.org/W2125354405","https://openalex.org/W2126821510","https://openalex.org/W2133062667","https://openalex.org/W2134374536","https://openalex.org/W2144714058","https://openalex.org/W2162301936","https://openalex.org/W2164733896","https://openalex.org/W2166484715","https://openalex.org/W2168249395","https://openalex.org/W2186252355","https://openalex.org/W2277239386","https://openalex.org/W2312205556","https://openalex.org/W2329386015","https://openalex.org/W2597580358","https://openalex.org/W4251361525","https://openalex.org/W4313308282","https://openalex.org/W4313377040","https://openalex.org/W6633487098"],"related_works":["https://openalex.org/W2587915541","https://openalex.org/W2342924512","https://openalex.org/W2600394651","https://openalex.org/W2597580358","https://openalex.org/W4242445656","https://openalex.org/W1987657194","https://openalex.org/W2797366882","https://openalex.org/W4254054694","https://openalex.org/W2107433579","https://openalex.org/W4413050444"],"abstract_inverted_index":{"We":[0],"report":[1],"on":[2],"12":[3,77,163],"consecutive":[4],"patients":[5,78,107,164,176],"with":[6,177,197],"advanced/metastatic":[7],"Ewing's":[8,178],"sarcoma":[9],"who":[10],"were":[11,43,101,108,122],"treated":[12],"as":[13],"a":[14,18,148,186],"separate":[15],"cohort":[16],"of":[17,22,75,161],"phase":[19,172],"1":[20,131,166,173],"trial":[21],"FANG":[23,138,180],"autologous":[24,50,114],"immunotherapy":[25,181],"(1":[26],"\u00d7":[27,29],"10(6)-2.5":[28],"10(7)":[30],"cells/intradermal":[31],"injection":[32],"each":[33],"month":[34,130,133],"for":[35,110],"minimum":[36],"4":[37,134],"months).":[38],"Safety":[39],"and":[40,69,97,103,119,194],"clinical":[41,202],"response":[42,47,112,128,151,190],"monitored.":[44],"Patient":[45],"immune":[46,189],"to":[48,113],"unmodified":[49],"tumor":[51,115,150,153],"cells":[52,65,116],"was":[53,93,139,168,182,195],"assessed":[54,109],"by":[55],"gamma":[56],"interferon-enzyme-linked":[57],"immunospot":[58],"(\u03b3IFN-ELISPOT)":[59],"assay":[60],"using":[61],"peripheral":[62],"blood":[63],"mononuclear":[64],"from":[66],"baseline":[67,118],"(pretreatment)":[68],"multiple":[70],"postvaccination":[71],"time":[72],"points.":[73],"None":[74],"the":[76],"(47":[79],"vaccinations)":[80],"developed":[81],"grade":[82],"2/3/4":[83],"drug-related":[84],"toxicity.":[85],"Median":[86],"product":[87],"release":[88],"granulocyte-macrophage":[89],"colony-stimulating":[90],"factor":[91],"expression":[92],"1,941":[94],"pg/10(6)":[95],"cells,":[96],"TGF\u03b21and":[98],"TGF\u03b22":[99],"knockdown":[100],"99":[102],"100%,":[104],"respectively.":[105],"Eight":[106],"ELISPOT":[111,127],"at":[117,129,165],"all":[120,142,192],"(100%)":[121],"negative.":[123],"In":[124,170],"contrast,":[125],"follow-up":[126],"or":[132],"(one":[135],"patient)":[136],"after":[137],"positive":[140],"in":[141,175,191],"eight":[143],"patients.":[144],"One":[145],"patient":[146],"achieved":[147],"partial":[149],"(38%":[152],"reduction,":[154],"RECIST":[155],"1.1).":[156],"The":[157],"Kaplan-Meier":[158],"estimated":[159],"survival":[160],"these":[162],"year":[167],"75%.":[169],"this":[171],"study":[174],"sarcoma,":[179],"well":[183],"tolerated,":[184],"elicited":[185],"tumor-specific":[187],"systemic":[188],"patients,":[193],"associated":[196],"favorable":[198],"1-year":[199],"survival.":[200],"Further":[201],"testing":[203],"is":[204],"indicated.":[205]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2321142363","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
